Cipro®

INN: ciprofloxacin

Approved for use in:

Crohn’s Disease (mild-severe)
Ulcerative Colitis (mild-severe)

Type/Class

Antibiotic

Delivery Route

Oral (tablet or suspension)

Health Canada Approval

1998

Storage

Tablet: store below 30°C.
Suspension: can be kept for 14 days when stored in refrigerator or at room temperature (5-25°C), store in upright position.

Use in Older Adults (65+)

Use with caution in individuals with impaired renal function.

Pregnancy Indication

Animal studies suggest this medicine is non-embryotoxic and non-teratogenic.

Breastfeeding Indication

Excreted in breast milk; potential for adverse reactions in breastfed infants.

Pediatric Indication

Safety and efficacy not established.

Learn More

View the Cipro® product monograph.